Delivery Order SPE2DB22D2206-SPE2DB26FDS72
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,522.89 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes on October 17, 2025, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $31,595.86 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of September 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,570.63 on July 14, 2025, for the supply of Orencia 125 mg/ml syringes. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $11,893.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Orencia 125 mg/ml syringes. This non-set-aside competitive award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $11,704.73 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under the company's larger pharmaceutical supply framework with the federal government. The product will be performed and delivered from AmerisourceBergen's facility in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Orencia 125 mg/mL syringes valued at $14,877.38. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement standards. The contract is performed from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orencia 125 mg/mL syringes valued at $9,779.31. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,711.89 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Orencia 125 mg/ml syringes. The contract carries a firm fixed price structure with no set-aside designation, reflecting competitive procurement procedures. The award is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a $5,590.59 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Orencia 125 mg/ml syringes. This competitively awarded, firm fixed-price contract is not set-aside and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance will be executed from the contractor's location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $9,176.76 on September 15, 2025, with completion scheduled for September 16, 2025. This non-competitive delivery order uses firm fixed pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with the DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Orencia is a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDS72Delivery Order
The Defense Logistics Agency awarded a $32,269.35 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/mL syringes, with an ultimate completion date of October 23, 2025. The contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award through open procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, vaccines, and related medical commodities across multiple therapeutic domains. The delivery order for Orencia, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions, reflects the company's ongoing role in fulfilling specialized pharmaceutical needs for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.3k | 10/22/25 |